First and only once-daily, nebulized bronchodilator has potential to address unmet needs of China's nearly 100 million chronic obstructive pulmonary disease (COPD) patients Read More »

93% overall response (13 of 14 patients) and 71% complete response rates (10 of 14 patients) in follicular lymphoma grades 1 to 3a treated with REGN1979 5 mg to 320 mg Read More »

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced that it has executed a pharmacy services agreement with Southside Specialty Pharmacy, further expanding access to treatment with Probuphine (buprenorphine) implant, Titan's novel maintenance treatment for Opioid Use Disorder (OUD) in eligible patients. Read More »

New venture leverages an innovative sourcing model to help Banner Health ensure clinicians have access to life-saving drugs in short supply Read More »

Lipscomb University joins as founding member; other universities encouraged to join Read More »

Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, announced the publication of a case study involving a cystic fibrosis patient who was successfully treated for a multidrug-resistant Pseudomonas aeruginosa infection with the Company's natural phage product, AP-PA01. Read More »

Accreditation Program Assures Best Practices and Security for Safe Drug and Device Distribution Read More »

Reneo Pharmaceuticals, a clinical stage pharmaceutical company, announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with deficits in cellular metabolism and energy production. Read More »

The National Association of Specialty Pharmacy (NASP) is extremely disappointed the administration did not initiate much needed reforms to ensure Medicare beneficiaries begin paying less at the pharmacy counter in 2020. Read More »

Prime Therapeutics LLC (Prime) announces it has earned URAC accreditation in Pharmacy Benefit Management (PBM). Read More »

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced the launch of a generic version of Delzicol®1 (mesalamine) delayed-release capsules, 400 mg, in the U.S. Read More »

All 140 CVS Pharmacy locations in Minnesota area now using time-delay safe technology Read More »

Abbott (NYSE: ABT) announced that m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). Read More »

Safe Rx announced its availability in California Kaiser Permanente pharmacies. Read More »

AmerisourceBergen issued the following announcement on April 24.Original source can be found here. Read More »

Rapha Capital Management, LLC (https://www.raphacap.com), an investment management firm located in Miami, Florida, and their associated entities announced their participation in a Series C financing for Poseida Therapeutics ("Poseida"). Read More »

Dr. Annabelle Manalo on Wednesday and Today met over 400 members of the Pharmacy Society of Wisconsin including each of its board members of the Pharmacy Society of Wisconsin. Read More »

Nationwide demand for local pharmacy model fuels expansion Read More »

Within a week of FDA approval, MAVENCLAD has formulary coverage with one of the leading pharmacy benefit managers in the U.S. Read More »

Large, randomized ALPINE trial showed both long-acting injectable medications effectively controlled schizophrenia symptoms throughout six-month study Read More »